Cancer rehabilitation has been defined in the scientific literature as a distinct field of medicine[1] that focuses on reducing or eliminating side-effects of cancer treatment and improving survivors' strength, ability to function and quality of life

This field is a subspecialty of Physical Medicine and Rehabilitation (PM&R), also known as physiatry and/or rehabilitation medicine.

Scope of the specialty

Cancer rehabilitation providers focus on improving each patient's functional status. Using an interdisciplinary model of care, professionals identify patients’ goals, improve their function, develop a patient and family centered plan of care that accounts for medical, physical, psychological and social components. The aim is helping patients improve their cancer-related symptoms and treatment side effects, while promoting optimal patient function at home, work and in the community.[1] Additionally, cancer rehabilitation physicians work on identifying musculoskeletal and neurologic problems and treat them with a variety of treatments including medications, procedures and therapy. Some of those procedures include, but are not limited to, various types of injections and other procedures. Therapeutic exercises include those guided by physical, occupational and speech therapists to work on specific motor or cognitive impairments as well as difficulties performing activities of daily living (ADLs) (dressing, bathing, toileting etc.) and instrumental activities of daily living (IADLs) such as house cleaning, shopping, etc.[2] However, patient-driven general exercise to maintain or improve endurance and overall functional status is also an important component of the rehabilitation process. Because cancer patients’ problems typically are complex and survivors have a high likelihood of developing physical, mental and functional issues, rehabilitation experts have recommended that cancer rehabilitation be integrated in oncology care early on.[3] Several clinical articles have highlighted the effectiveness of rehabilitation interventions before, during, and after cancer treatment to screen for, assess, and treat patients’ functional needs.[2]

Practice

Cancer Rehabilitation Team

Physicians that specialize in PM&R are usually called physiatrists (or rehabilitation medicine physicians). These doctors lead interdisciplinary teams, and they are specialists in the non-surgical treatment of musculoskeletal problems and rehabilitation medicine. Physiatrists should ideally be a part of the cancer care team as they perform diagnostic evaluations, provide unique expertise in prescribing medications, perform injections and prescribe appropriate splints and other devices to treat non-cancerous conditions that are a result of cancer treatments or the cancer itself.[3][4] Other potential members of the cancer rehabilitation team include, but are not limited to, physical and occupational therapists, speech language pathologists, nurses, exercise physiologists, oncology social workers, case managers and psychologists.

Patient Assessment

The cancer rehabilitation team evaluates and treats patients for various orthopedic, neurological and medical conditions caused by cancer or cancer-directed treatment (e.g. chemotherapy) that can significantly affect survivors’ function and quality of life. These are some of the areas that the cancer rehabilitation team may focus on:[5]

Cancer Rehabilitation Clinical Models

Hospital Care

Hospital-based cancer rehabilitation is provided in inpatient rehabilitation facilities, skilled nursing facilities, long-term care hospitals and hospice facilities. Cancer patients undergo a formal functional assessment to identify impairments with the aim of providing comprehensive therapy and medical care to improve their overall functional status. During this care, a variety of services are offered including, but not limited to: physical therapy, occupational therapy, speech therapy, nutrition, psychology and nursing.[6]

Home Care

In these programs, patients receive services directly at home to provide help with symptom management, wound care, vital signs monitoring and medication management. These are typically nurse-driven programs, however, they could also be driven by therapists when the focus is function. In those cases, the home services are directed to provide patients with home therapists to undergo home driven physical, occupational or speech therapy programs.[6]

Outpatient care

These programs promote identification and management of treatment toxicities that affect function in an outpatient setting. They offer a variety of services to address physical and emotional needs of patients. Some of these services are provided by physicians, nurses, psychologists and therapists. However, these programs could be very different from one institution to another.[6]

Prehabilitation

Cancer prehabilitation refers to the assessments and interventions that are conducted just after diagnosis but before cancer treatment begins. A panel of experts has highlighted the importance of establishing rehabilitation services prior to the oncological treatment to optimize tolerance to surgery or adjuvant treatments, minimize toxicity and improve outcomes. Recent clinical studies have shown that cancer prehabilitation and rehabilitation can increase function and may improve outcomes and disability rates.[7] For example, a 2020 study looking at men awaiting surgery for urological cancer showed that high-intensity interval training (HIIT) may improve heart and lung fitness within a month before their surgery.[8][9]

References

  1. ^ a b Silver, Julie K. (2014-07-15). "Cancer rehabilitation and prehabilitation may reduce disability and early retirement". Cancer. 120 (14): 2072–2076. doi:10.1002/cncr.28713. ISSN 1097-0142. PMID 24752917.
  2. ^ a b Silver, Julie K.; Raj, Vishwa S.; Fu, Jack B.; Wisotzky, Eric M.; Smith, Sean Robinson; Kirch, Rebecca A. (2015-12-01). "Cancer rehabilitation and palliative care: critical components in the delivery of high-quality oncology services". Supportive Care in Cancer. 23 (12): 3633–3643. doi:10.1007/s00520-015-2916-1. ISSN 0941-4355. PMID 26314705. S2CID 8718461.
  3. ^ a b Raj, Vishwa S.; Silver, Julie K.; Pugh, Terrence M.; Fu, Jack B. (2017). "Palliative Care and Physiatry in the Oncology Care Spectrum". Physical Medicine and Rehabilitation Clinics of North America. 28 (1): 35–47. doi:10.1016/j.pmr.2016.08.006. PMID 27912999.
  4. ^ Silver, Julie K. (2015-02-01). "Cancer Prehabilitation and its Role in Improving Health Outcomes and Reducing Health Care Costs". Seminars in Oncology Nursing. 31 (1): 13–30. doi:10.1016/j.soncn.2014.11.003. ISSN 0749-2081. PMID 25636392.
  5. ^ Silver, Julie K.; Baima, Jennifer; Mayer, R. Samuel (2013-09-01). "Impairment-driven cancer rehabilitation: An essential component of quality care and survivorship". CA: A Cancer Journal for Clinicians. 63 (5): 295–317. doi:10.3322/caac.21186. ISSN 1542-4863. PMID 23856764.
  6. ^ a b c Stout, Nicole L.; Silver, Julie K.; Raj, Vishwa S.; Rowland, Julia; Gerber, Lynn; Cheville, Andrea; Ness, Kirsten K.; Radomski, Mary; Nitkin, Ralph (2016-11-01). "Toward a National Initiative in Cancer Rehabilitation: Recommendations From a Subject Matter Expert Group". Archives of Physical Medicine and Rehabilitation. 97 (11): 2006–2015. doi:10.1016/j.apmr.2016.05.002. ISSN 0003-9993. PMID 27237580.
  7. ^ Silver, Julie K.; Baima, Jennifer (2013). "Cancer Prehabilitation". American Journal of Physical Medicine & Rehabilitation. 92 (8): 715–727. doi:10.1097/phm.0b013e31829b4afe. PMID 23756434.
  8. ^ "High-intensity interval training rapidly improves fitness in patients awaiting surgery for urological cancer". NIHR Evidence (Plain English summary). National Institute for Health and Care Research. 2020-06-05. doi:10.3310/alert_40363. S2CID 242684291.
  9. ^ Blackwell, J. E. M.; Doleman, B.; Boereboom, C. L; Morton, A.; Williams, S.; Atherton, P.; Smith, K.; Williams, J. P.; Phillips, B. E.; Lund, J. N. (10 March 2020). "High-intensity interval training produces a significant improvement in fitness in less than 31 days before surgery for urological cancer: a randomised control trial". Prostate Cancer and Prostatic Diseases. 23 (4): 696–704. doi:10.1038/s41391-020-0219-1. ISSN 1365-7852. PMC 7655502. PMID 32157250.
Categories